34 items found

Tags: 110309 Infectious Diseases 60506 Virology Biotechnology Pharmacology therapy

Filter Results
  • dataset

    Demographic data

    **P<0.01; SD, standard deviation; Max/Min, maximal/minimal.The number of participants did not differ between genders (Chi-square P>0.05). The dancer and pianist groups...
  • dataset

    Themes and sub-themes identified, with example quotations.

    Themes and sub-themes identified, with example quotations.
  • dataset

    Patient’s demographics and clinical characteristics (n = 362).

    Patient’s demographics and clinical characteristics (n = 362).
  • dataset

    Model parameters.

    aSpecified with reference to Cook [30] and Waage et al. [36] using distributions defined in Biosecurity Australia [31]; b Derived from Sapoukhina et al. [37]; c ABS [6], Note...
  • dataset

    Patient data.

    Detailed clinical, electrodiagnostic and sonographic findings of all patients. (AD—active denervation, APD—anterior-posterior diameter, BR—brachioradialis muscle, ECR—extensor...
  • dataset

    Phase I randomized clinical trial of N-acetylcysteine in combination with an ...

    BackgroundThere are no therapies shown to improve outcome after severe traumatic brain injury (TBI) in humans, a leading cause of morbidity and mortality. We sought to verify...
  • dataset

    Primers used in this study.

    a Liu et al., 2011 [19]. b Ji et al., 2007 [20]. c Wei et al., 2010 [21]. d Noteborn et al., 2013 [22]. *Positions correspond to: IBDV (JQ684022), IBV (KJ425500), AEV...
  • dataset

    Patient and treatment characteristics.

    aPrimary disease: CRC = colorectal carcinoma; NPC = nasopharyngeal carcinoma; MC = mammary carcinoma; HCC = hepatocellular carcinoma.bLobes treated: W = whole liver treatment; L...
  • dataset

    r37980778c78--6e7664f85a7f9eda84218c4636618251

    Factors associated with the prescription of the recommended therapies in bivariate analysis.
  • dataset

    Summary of included studies.

    *Sample size calculated excluding non-active controls; brackets indicate final number used in evaluation, if reported. APAI: Acholi Psychosocial Assessment Instrument; BASC:...
  • dataset

    Socio-demographic characteristics <i>Helicobacter pylori</i> infected patient...

    Socio-demographic characteristics Helicobacter pylori infected patients attending in selected healthcare institutions at Bahir Dar City Administration, May 2016 to April 2018 (n...
  • dataset

    r37980778c78--ca8a968646aed13788ddf243dd9d0e8d

    Cases of children abandoning conventional therapy for traditional and complementary medicine (T&CM) identified through primary and secondary searches.
  • dataset

    Baseline characteristics of the study population.

    Values are expressed as medians (range or percentage). * Hypertension: Yes = systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or treated with...
  • dataset

    r37980778c78--46ed3f244e2cad85436ee2f0e0efff7c

    Medical information and Helicobacter pylori eradication rate of standard triple therapy among patients in selected healthcare institutions at Bahir Dar City Administration, May...
  • dataset

    Patient outcomes.

    †median (range) days for all patients.*p value for cross tabulation of all MRS categories.
  • dataset

    Clinical characteristics.

    Infants are scored according to the appearance of their lesions on the early scan. For the 21 infants that only showed lesions at TEA, the appearance at TEA is used....
  • dataset

    Logistic regression analysis of factors associated with <i>H</i>. <i>pylori</...

    Logistic regression analysis of factors associated with H. pylori eradication triple therapy in selected healthcare institutions at Bahir Dar City Administration, May 2016 to...
  • dataset

    Information on protocol compliance.

    Information on protocol compliance.
  • dataset

    r37980778c78--d723d2bfbf55b7dec217e5b344bd9058

    Medical interventions.
  • dataset

    r37980778c78--0cf33b28923483a65289551d586e5494

    Factors associated with the prescription of the recommended therapies in multivariate analysis.